AXGN
Price
$18.09
Change
-$0.34 (-1.84%)
Updated
Jan 17 closing price
Capitalization
348.67M
43 days until earnings call
ICUI
Price
$163.87
Change
-$2.20 (-1.32%)
Updated
Jan 17 closing price
Capitalization
2.55B
43 days until earnings call
Ad is loading...

AXGN vs ICUI

Header iconAXGN vs ICUI Comparison
Open Charts AXGN vs ICUIBanner chart's image
Axogen
Price$18.09
Change-$0.34 (-1.84%)
Volume$668.75K
Capitalization348.67M
ICU Medical
Price$163.87
Change-$2.20 (-1.32%)
Volume$219.17K
Capitalization2.55B
AXGN vs ICUI Comparison Chart
Loading...
AXGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ICUI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AXGN vs. ICUI commentary
Jan 21, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AXGN is a Hold and ICUI is a Hold.

Ad is loading...
COMPARISON
Comparison
Jan 21, 2025
Stock price -- (AXGN: $18.09 vs. ICUI: $163.87)
Brand notoriety: AXGN and ICUI are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: AXGN: 164% vs. ICUI: 96%
Market capitalization -- AXGN: $348.67M vs. ICUI: $2.55B
AXGN [@Medical Specialties] is valued at $348.67M. ICUI’s [@Medical Specialties] market capitalization is $2.55B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.11B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AXGN’s FA Score shows that 0 FA rating(s) are green whileICUI’s FA Score has 1 green FA rating(s).

  • AXGN’s FA Score: 0 green, 5 red.
  • ICUI’s FA Score: 1 green, 4 red.
According to our system of comparison, both AXGN and ICUI are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AXGN’s TA Score shows that 3 TA indicator(s) are bullish while ICUI’s TA Score has 3 bullish TA indicator(s).

  • AXGN’s TA Score: 3 bullish, 4 bearish.
  • ICUI’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, both AXGN and ICUI are a bad buy in the short-term.

Price Growth

AXGN (@Medical Specialties) experienced а +0.22% price change this week, while ICUI (@Medical Specialties) price change was +6.17% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +0.97%. For the same industry, the average monthly price growth was +5.53%, and the average quarterly price growth was +1.10%.

Reported Earning Dates

AXGN is expected to report earnings on May 07, 2025.

ICUI is expected to report earnings on May 12, 2025.

Industries' Descriptions

@Medical Specialties (+0.97% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ICUI($2.55B) has a higher market cap than AXGN($349M). AXGN YTD gains are higher at: 9.769 vs. ICUI (5.607). ICUI has higher annual earnings (EBITDA): 253M vs. AXGN (-13.33M). ICUI has more cash in the bank: 255M vs. AXGN (31M). AXGN has less debt than ICUI: AXGN (69.3M) vs ICUI (1.7B). ICUI has higher revenues than AXGN: ICUI (2.26B) vs AXGN (159M).
AXGNICUIAXGN / ICUI
Capitalization349M2.55B14%
EBITDA-13.33M253M-5%
Gain YTD9.7695.607174%
P/E RatioN/A333.33-
Revenue159M2.26B7%
Total Cash31M255M12%
Total Debt69.3M1.7B4%
FUNDAMENTALS RATINGS
AXGN vs ICUI: Fundamental Ratings
AXGN
ICUI
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
49
Fair valued
92
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9491
PRICE GROWTH RATING
1..100
3641
P/E GROWTH RATING
1..100
1002
SEASONALITY SCORE
1..100
25n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

AXGN's Valuation (49) in the Medical Specialties industry is somewhat better than the same rating for ICUI (92). This means that AXGN’s stock grew somewhat faster than ICUI’s over the last 12 months.

AXGN's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as ICUI (100). This means that AXGN’s stock grew similarly to ICUI’s over the last 12 months.

ICUI's SMR Rating (91) in the Medical Specialties industry is in the same range as AXGN (94). This means that ICUI’s stock grew similarly to AXGN’s over the last 12 months.

AXGN's Price Growth Rating (36) in the Medical Specialties industry is in the same range as ICUI (41). This means that AXGN’s stock grew similarly to ICUI’s over the last 12 months.

ICUI's P/E Growth Rating (2) in the Medical Specialties industry is significantly better than the same rating for AXGN (100). This means that ICUI’s stock grew significantly faster than AXGN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AXGNICUI
RSI
ODDS (%)
Bearish Trend 13 days ago
73%
N/A
Stochastic
ODDS (%)
Bullish Trend 13 days ago
84%
Bearish Trend 13 days ago
66%
Momentum
ODDS (%)
Bearish Trend 13 days ago
84%
Bullish Trend 13 days ago
64%
MACD
ODDS (%)
Bearish Trend 13 days ago
84%
Bullish Trend 13 days ago
67%
TrendWeek
ODDS (%)
Bearish Trend 13 days ago
84%
Bullish Trend 13 days ago
67%
TrendMonth
ODDS (%)
Bullish Trend 13 days ago
83%
Bullish Trend 13 days ago
66%
Advances
ODDS (%)
Bullish Trend 13 days ago
79%
Bullish Trend 15 days ago
68%
Declines
ODDS (%)
Bearish Trend 15 days ago
85%
Bearish Trend 13 days ago
68%
BollingerBands
ODDS (%)
N/A
Bearish Trend 13 days ago
82%
Aroon
ODDS (%)
Bullish Trend 13 days ago
87%
Bearish Trend 13 days ago
69%
View a ticker or compare two or three
Ad is loading...
AXGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ICUI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TILRX28.900.40
+1.40%
Nuveen Large Cap Growth R
IGEAX79.540.82
+1.04%
VY® T. Rowe Price Growth Equity A
JMIGX26.980.26
+0.97%
Jacob Discovery Fd Instl
DNLVX19.820.10
+0.51%
Dunham Large Cap Value N
MNBIX19.580.07
+0.36%
Manning & Napier Pro-Blend Extnd Term I

AXGN and

Correlation & Price change

A.I.dvisor indicates that over the last year, AXGN has been loosely correlated with TCMD. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if AXGN jumps, then TCMD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AXGN
1D Price
Change %
AXGN100%
-1.84%
TCMD - AXGN
43%
Loosely correlated
-0.17%
ICUI - AXGN
40%
Loosely correlated
-1.32%
TMDX - AXGN
38%
Loosely correlated
-1.41%
CERS - AXGN
37%
Loosely correlated
-1.65%
XRAY - AXGN
35%
Loosely correlated
+1.79%
More

ICUI and

Correlation & Price change

A.I.dvisor indicates that over the last year, ICUI has been loosely correlated with CLPT. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if ICUI jumps, then CLPT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ICUI
1D Price
Change %
ICUI100%
-1.32%
CLPT - ICUI
45%
Loosely correlated
+0.53%
HBIO - ICUI
43%
Loosely correlated
+0.52%
UTMD - ICUI
43%
Loosely correlated
+0.27%
VMD - ICUI
42%
Loosely correlated
-0.24%
GKOS - ICUI
41%
Loosely correlated
-0.08%
More